IDYA
IDEAYA Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$33.81
+2.92%Margins
Gross margin
100.0%
EBITDA margin
-77.6%
EBIT margin
-92.7%
Net margin
-74.8%
FCF margin
-48.6%
-14.6%
Return on equity
-13.4%
Return on assets
-17.7%
Return on invested capital
0.20x
Asset turnover
-$111.7M
Cash from operations
$8.59
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026